A method of screening a human or animal subject for early determining the risk of developing a known disease or condition or of identifying the presence of the known disease or condition in the subject, comprising:
- a. obtaining first subject data, wherein said first subject data includes results of a first set of blood tests collected at a first blood collection time shortly after a subject is admitted to an emergency department, an urgent care facility, an intensive care unit, or a medical providers office, wherein said first subject data includes at least a reduced set of tests from a basic metabolic panel (BMP) and a complete blood count (CBC) panel;
- b. classifying said first subject data, wherein said classifying includes determining risk of the subject having or developing the known disease or condition by using said first subject data in a machine learning classification system, wherein said classification system includes a machine learning model previously trained on data from a positive group of training subjects who received a diagnosis of the disease or condition and from a negative group of training subjects who were not diagnosed to have the disease or condition;
- and
- c. reporting said risk of the subject having or developing the known disease or condition as determined from said first subject data by said machine learning classification system, wherein said reporting is provided in a first risk report.